• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Femtech Startups Nearly Double Funding Dollars from Last Year, But Still Make up Small Percent of Market

Share:

October 7, 2021

Digital health startups in the U.S. serving women and other people with female biology raised $1.3 billion through August 2021, nearly doubling 2020’s full-year total of $774 million, according to a new report by Rock Health.

Rock Health is calling this market segment women+ health, describing tools that relate to cisgender women’s health needs as well as the needs of transgender and nonbinary people who may access similar care.

Although 2021’s $1.3 billion is the most funding dollars recorded in the women+ space, it still only makes up 5% of digital health funding overall since Rock Health began tracking in 2011. So far, women+ funding accounts for 7% of this year’s digital health deals, below the record of 11% in 2019.

The pregnancy, postpartum, and parenthood sector still dominates new companies founded in the past five years, historically a large area of focus for women’s digital health. Rock’s report notes that’s a limitation in the space.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“However, with less than 45% of the U.S. female population at reproductive age, and the U.S. birth rate at its lowest record to date, equivocacy between pregnancy, postpartum and parenthood support and women+ health can leave the majority of women+ deprioritized in the current scope of digital health innovation,” the report’s authors wrote.

But that pregnancy and parenthood focus could be shifting. In 2021 so far, the top-funded sector was preventative and primary care, bringing in $668 million. Fertility support brought in $330 million, and the pregnancy, postpartum and parenthood area scooped up $316 million.

Funding in the perimenopause and menopause sector, an area of women+ health that is frequently stigmatized, doubled from 2019 to 2021.

But there are some gaps in the women+ space. Even though behavioral health funding is surging overall, only 4% of that funding went to companies offering solutions for women+, and chronic disease care for this market hasn’t received any funding so far this year.

Other places for growth include digital therapeutics for women+ health; addressing gaps in solutions for miscarriages, abortions, and surgeries such as hysterectomies and mastectomies; addressing health needs with a focus on intersectionality; women+-focused primary and chronic care; and ensuring women+ groups are equally represented in clinical research.

WHY IT MATTERS

Women utilize healthcare services more often than men, in part because of the need for reproductive care, and make the majority of healthcare decisions for their children, according to a brief by the Department of Labor.

But nearly one in four women reported having trouble paying medical bills in the past year, with more than half saying it was due, at least in part, to the COVID-19 pandemic, according to an April report by the Kaiser Family Foundation. KFF also found women were more likely to delay care during the pandemic compared with men.

Rock Health noted women are also using digital health tools like video telehealth, wearables, and health trackers at lower rates than men; for instance, only 36% of women said they owned a wearable in 2020 compared with 49% of men.

THE LARGER TREND

Some large digital health deals in the women+ space in 2021 include Tia, which raised $100 million earlier this month, and Maven Clinic, which scooped up $110 million in August, bringing its total raised to more than $200 million. Both operate in the women’s primary care space.

Last month, diagnostics and drug development giant Labcorp bought Ovia Health, a digital family health platform that includes resources for period tracking, fertility, child development, and parenting.

“At Rock Health, we’re hopeful that women+ digital health will increasingly get the Talkspace, attention, and funding from investors it deserves to continue to serve the complex, evolving needs of the women+ population,” the Rock Health report authors wrote.

“The digital health ecosystem is changing at lightning speed, and while funding for nearly all areas within digital health has increased since the start of the pandemic, digital health founders and investors have yet to realize the full potential in designing equitable and comprehensive care offerings that serve women+.”

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Canopy Growth Buys Out Cannabis Research Joint VentureCanopy Growth Buys Out Cannabis Research Joint Venture
  • Sanofi, Advent finally shake hands on $2.2B European generics saleSanofi, Advent finally shake hands on $2.2B European generics sale
  • NeuroFlow, Atlantic Health System Partner to Launch Collaborative Care ModelNeuroFlow, Atlantic Health System Partner to Launch Collaborative Care Model
  • DrChrono Partners with Ricoh to Automatically Scan Patient ID, Medical Documentation and Explanation of Benefits into Healthcare PlatformDrChrono Partners with Ricoh to Automatically Scan Patient ID, Medical Documentation and Explanation of Benefits into Healthcare Platform
  • Fujifilm & Volpara Partner to Help Clinicians Determine Patient Breast DensityFujifilm & Volpara Partner to Help Clinicians Determine Patient Breast Density
  • XOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by OrganonXOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon
  • Trice Medical Continues Mission of Making Elective Procedures More Efficient Through the Acquisition of Tenex HealthTrice Medical Continues Mission of Making Elective Procedures More Efficient Through the Acquisition of Tenex Health
  • ScriptDrop Raises $15M Series A For Pharmacy Delivery PlatformScriptDrop Raises $15M Series A For Pharmacy Delivery Platform

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications